Predicting non‐sentinel lymph node metastasis in Australian breast cancer patients: are the nomograms still useful in the post‐Z0011 era?

@article{Tapia2019PredictingNL,
  title={Predicting non‐sentinel lymph node metastasis in Australian breast cancer patients: are the nomograms still useful in the post‐Z0011 era?},
  author={G. Tapia and Victoria Ying and A. D. Di Re and A. Stellin and T. Y. Cai and S. Warrier},
  journal={ANZ Journal of Surgery},
  year={2019},
  volume={89}
}
Axillary lymph node dissection (ALND) can be avoided in breast cancer patients with low‐volume disease in the sentinel lymph nodes (SLNs) according to Z0011 trial. We believe that nomograms developed for predicting non‐sentinel lymph node (NSLN) metastases can guide the axillary treatment in patients who do not fully match the criteria of Z0011 study. We identified risk factors and evaluated the performance of three nomograms to predict NSLN status in patients with positive SLNs. 
3 Citations

References

SHOWING 1-10 OF 32 REFERENCES
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
  • 727
  • Highly Influential
International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
  • 70
  • PDF
Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity.
  • N. Soni, H. Carmalt, D. Gillett, A. Spillane
  • Medicine
  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2005
  • 84
...
1
2
3
4
...